Clinical trial · Observational
Quality of Life in Advanced Gastric Cancer Patients Receiving Neoadjuvant Chemotherapy
Quality of Life in Patient With Neoadjuvant Chemotherapy Followed by Surgery Versus Surgery Alone for Locally Advanced Gastric Cancer
NCT04408859CI-TRIAL-00045314unknownClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
The purpose of this study is to explore the influence of neoadjuvant chemotherapy in the long term quality of life with advanced gastric cancer patients.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| QOL; Quality of Life;Gastric Cancer; Gastrectomy;Neoadjuvant Chemotherapy | — | UNRESOLVED | — |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Neoadjuvant Chemotherapy | Drug | — | UNRESOLVED |
Design
Arms and outcomes
Arms (2)
- label
- NACS
- description
- The patients with advanced gastric cancer who received neoadjuvant chemotherapy followed by surgery（NACS）.
- interventionNames
- Drug: Neoadjuvant Chemotherapy
- label
- SA
- description
- The patients with advanced gastric cancer who received surgery alone.
Primary outcomes (1)
- measure
- Quality of life index
- timeFrame
- 2 years
- description
- The change of quality of life index during the 2 years after surgery.
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: * Patients age older than 18 years (including 18 years old); * Diagnosis of adenocarcinoma of the stomach * The clinic stage is ≥T2 and any N stage * Patient had curative surgical resection, including proximal, distal, or total gastrectomy Exclusion Criteria: * Psychiatric or psychological abnormality precluding informed consent or ability to complete questionnaires * Non-psychiatric disorder causing a lack of capacity to give consent or an inability to complete questionnaires (ie dementia, stroke) * Early gastric cancer.
References
Publications (0)
Data not yet available
No reference posted for this study.